DexTech Medical AB, Year-end report July 1, 2023 - June 30, 2024
Summary of year-end report Fourth quarter (2024-04-01 – 2024-06-30) · Net sales amounted to SEK 0.0 million (0.0) · Operating profit amounted to SEK -1.6 million (-1.3) · Earnings per share* SEK -0.07 (-0.06) Full year (2023-07-01 – 2024-06-30) · Net sales amounted to SEK 0.0 million (0.0) · Operating profit amounted to SEK -5.5 million (-4.9) · Earnings per share* SEK -0.25 (-0.25) · Cash and cash equivalents at the end of the financial year amounted to SEK 19.0 (25.2) million * Before and after dilution. Earnings per share: Profit for the period divided